Preview

Nephrology (Saint-Petersburg)

Advanced search

Course and treatment characteristics of “obstetric” atypical hemolytic-uremic syndrome (aHUS)

Abstract

It is presented the case of rare aHUS that developed late in the second trimester of pregnancy, and showed severe multiple organ pathology, including the kidneys, heart, lungs, nervous system and placenta. As a result, early diagnosis and timely plazmotherapy started in conjunction with LMWH acute TMA eliminated with full restoration of function of damaged organs.

About the Authors

Y. V. Korotchaeva
I.M.Sechenov First Moscow State Medical University
Russian Federation


N. L. Kozlovskaya
I.M.Sechenov First Moscow State Medical University
Russian Federation


T. V. Bondarenko
Clinical city hospital named A.K. Eramishantceva
Russian Federation


G. A. Veselov
Clinical city hospital named A.K. Eramishantceva
Russian Federation


References

1. Tsai H.M. A Mechanistic Approach to the Diagnosis and Management of Atypical Hemolytic Uremic Syndrome. Transfus Med Rev 2014; Oct; 28(4): 187-197.

2. Fakhouri F., Fremeaux-Bacchi V. Does hemolytic uremic syndrome differ from thrombotic thrombocytopenic purpura. Nat Clin Pract Nephrol 2007; 3: 679-687.

3. Noris M., Giuseppe R. Atypical hemolytic-uremic syndrome. N Engl J Med 2009; 361: 1676-1687.

4. Fakhouri F1., Vercel C., Frémeaux-Bacchi V. Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy. Clin J Am Soc Nephrol. 2012 Dec; 7(12): 2100-2106.

5. Meri S. Complement activation in diseases presenting with thrombotic microangiopathy. Eur J Intern Med 2013 Sep; 24(6): 496-502.

6. McMinn J.R., George J.N. Evaluation of women with clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome during pregnancy. J Clin l Apheresis 2001; 16: 202-209.

7. Owens M.Y., Martin J.N.Jr., Wallace K. et al. Postpartum thrombotic microangiopathic syndrome. Transfus Apher Sci 2013 Feb; 48(1): 51-57

8. Han-Mou Tsai. Untying the Knot of Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome. 2013; 126 (3): 200-209

9. Козловская Н.Л., Меркушева Л.И., КирсановаТ.В. и др. Особенности течения и исхода атипичного гемолитико-уремического синдрома при беременности. Клиническая Нефрология 2012; 3: 44-49 [Kozlovskaia N.L., Merkusheva L.I., KirsanovaT.V. i dr. Osobennosti techeniia i is-hoda atipichnogo gemolitiko-uremicheskogo sindroma pri beremennosti. Cli-nicheskaia Nefrologiia 2012; 3: 44-49]

10. Noris M., Caprioli J., Bresin E. et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am SocNephrol 2010; 5: 1844-1859

11. Noris M1., Remuzzi G. Thrombotic microangiopathy after kidney transplantation. Am J Transplant2010 Jul; 10(7): 1517-1523

12. Ganesan C., Maynard S.E. Acute kidney injury in pregnancy: the thrombotic microangiopathies. J Nephrol 2011; 24: 554-563

13. Fakhouri F., Roumenina L., Provot F. et al. Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations. J Am Soc Nephrol 2010; 21: 859-867.

14. Sanches-Luseros A., Farias С. Von Willebrand factor-cleaving protease (ADAMTS-13) activity in normal non-pregnant women, pregnant and postdelivery women. Thromb. Haemost 2004; 92: 1320-1326.

15. Amara U., Rittrisch D., Flierl M. et al. Interaction between the coagulation and complement system. Adv Exp Med Biol 2008; 632: 71-79

16. Козловская Н.Л. Антикоагулянты в практике нефролога. Клиническая нефрология 2011; 1: 15-22 [Kozlovskaia N.L. Antikoagulianty' v praktike nefrologa. Clinicheskaia nefrolo-giia 2011; 1: 15-22]

17. Loirat C., Garnier A., Sellier-Leclerc A.L. et al. Plasmatherapy in atypical hemolytic uremic syndrome. Semin Thromb Hemost 2010; 36: 673-681


Review

For citations:


Korotchaeva Y.V., Kozlovskaya N.L., Bondarenko T.V., Veselov G.A. Course and treatment characteristics of “obstetric” atypical hemolytic-uremic syndrome (aHUS). Nephrology (Saint-Petersburg). 2015;19(2):76-81. (In Russ.)

Views: 439


ISSN 1561-6274 (Print)
ISSN 2541-9439 (Online)